Literature DB >> 12890126

Prevalence of atrial septal aneurysm in patients with migraine: an echocardiographic study.

S Carerj1, M C Narbone, C Zito, S Serra, S Coglitore, P Pugliatti, F Luzza, F Arrigo, G Oreto.   

Abstract

OBJECTIVE: To evaluate the prevalence of atrial septal aneurysm in patients with migraine.
BACKGROUND: Migraine has long been considered a risk factor for stroke. Atrial septal aneurysm is often observed in young patients with ischemic stroke and is frequently associated with other conditions potentially leading to embolism.
METHODS: We performed a transthoracic echocardiogram in 90 consecutive patients (65 women and 25 men; mean age, 35.3 years [standard deviation, 9]) with migraine but free from cerebral and cardiovascular disease and in 53 control subjects (37 women and 16 men; mean age, 34 years [standard deviation, 10]). The diagnosis of atrial septal aneurysm was performed according to Olivares-Reyes criteria. A transesophageal echocardiogram also was performed in 75 patients with migraine (83.3%).
RESULTS: The prevalence of isolated atrial septal aneurysm was higher in patients with migraine with aura (28.5%) than in patients with migraine without aura (3.6%) (P <.005) or in control subjects (1.9%) (P <.005).
CONCLUSIONS: Our data suggest a role of atrial septal aneurysm in the genesis of aura in patients with migraine.

Entities:  

Mesh:

Year:  2003        PMID: 12890126     DOI: 10.1046/j.1526-4610.2003.03129.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  9 in total

1.  Electrocardiography-gated dual-source computed tomography in the detection of atrial septal aneurysm.

Authors:  Lixiang Xie; Zhongxiao Liu; Xiuli Zhang; Kai Xu; Qian Xu; Li Lu; Chunfeng Hu; Shuguang Han; Jingjing Li
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

Review 2.  Migraine with aura: conventional and non-conventional treatments.

Authors:  Giovanni D'Andrea; Davide Colavito; Maurizio Dalle Carbonare; Alberta Leon
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 3.  The risk of stroke in patients with migraine and implications for migraine management.

Authors:  Gretchen E Tietjen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  "Hidden Danger" a case report on interatrial septal aneurysm.

Authors:  Carolina Carcano; Jacobo Kirsch
Journal:  Int J Cardiovasc Imaging       Date:  2011-09-18       Impact factor: 2.357

Review 5.  The migraine association with cardiac anomalies, cardiovascular disease, and stroke.

Authors:  Todd J Schwedt
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

Review 6.  How to Understand Patent Foramen Ovale Clinical Significance: Part I.

Authors:  Gabriella Falanga; Scipione Carerj; Giuseppe Oreto; Bijoy K Khandheria; Concetta Zito
Journal:  J Cardiovasc Echogr       Date:  2014 Oct-Dec

Review 7.  Comorbidities of primary headache disorders: a literature review with meta-analysis.

Authors:  Valeria Caponnetto; Manuela Deodato; Paolo Martelletti; Alberto Raggi; Micaela Robotti; Maria Koutsokera; Valeria Pozzilli; Cristina Galati; Giovanna Nocera; Eleonora De Matteis; Gioacchino De Vanna; Emanuela Fellini; Gleni Halili; Daniele Martinelli; Gabriele Nalli; Serena Serratore; Irene Tramacere
Journal:  J Headache Pain       Date:  2021-07-14       Impact factor: 7.277

8.  Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal characteristics.

Authors:  Jill T Jesurum; Cindy J Fuller; Carles A Velez; Merrill P Spencer; Kimberly A Krabill; William H Likosky; William A Gray; John V Olsen; Mark Reisman
Journal:  J Headache Pain       Date:  2007-09-24       Impact factor: 7.277

9.  Transcranial Doppler ultrasonography should it be the first choice for persistent foramen ovale screening?

Authors:  Monika Komar; Maria Olszowska; Tadeusz Przewłocki; Jakub Podolec; Jakub Stępniewski; Bartosz Sobień; Rafał Badacz; Anna Kabłak-Ziembicka; Lidia Tomkiewicz-Pająk; Piotr Podolec
Journal:  Cardiovasc Ultrasound       Date:  2014-05-22       Impact factor: 2.062

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.